To test for potential co-localization of TRPA1 and FGFR2, we performed a Duolink proximity ligation assay (PLA) in HCC-515 cells using antibodies that are targeted against endogenous FGFR2 and TRPA1 (Fig. 1d). This evidence concerns the gene TRPA1 and hepatocellular carcinoma.